bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.10.05.756556

A permeable G310 constriction limits K+ flux in the activated KCNQ2 pore and is disrupted by the encephalopathy variant G310S

Abstract

KCNQ2 (Kv7.2) subunits contribute to the channels that carry the neuronal M-current, and variants in KCNQ2 cause epilepsies that range from self-limited neonatal seizures to developmental and epileptic encephalopathy (DEE). Structures of KCNQ2 bound to PIP2 and cannabidiol show a widened activation gate, yet it has remained unclear which point of the activated pore limits K+ flux and how DEE variants at that point act. We simulated the KCNQ2 pore domain (PDB 8J01) in a POPC bilayer under an applied field of about 565 mV, restraining only the terminal residues of S5 and S6 so that G310 and S314 were free. The activated pore conducted K+ at 4.3 pS (95% CI 2.5-6.9; 17 net filter crossings in 1120 ns over four replicas), while the closed-state pore (PDB 7CR3) conducted none in 560 ns. Conduction proceeded by knock-on through a filter that was doubly occupied in 84-92% of frames. Along S6 the narrowest position of the activated pore was not the canonical gate residue S314 but the glycine of the Pro-Ala-Gly motif, G310: activation widens S314 by 0.37 nm but G310 by only 0.07 nm, and restraining G310 to its closed-state width in one replica abolished gate crossings. The DEE variant G310S reduced conduction about six-fold (G310S/wild-type ratio 0.16, 95% CI 0.02-0.66; p = 0.003). Its serine hydroxyls project into the constriction and halve the water column in the G310 plane (8.7 to 4.7 waters), an effect reproduced in CHARMM36m (9.9 to 4.3). The first coordination shell of a K+ ion at the constriction was, however, conserved (6.3 vs 6.5 oxygens), because the serine hydroxyls replace the waters they displace. The hydroxyls did not retain the ion: contacts lasted tens of picoseconds, and ions were instead turned back at the serine ring, fewer reaching the gate plane (45 vs 79 excursions per microsecond) and fewer of those crossing it (5% vs 23%). In mixed tetramers carrying one or two variant subunits the effect on the water column was additive, each subunit removing about a quarter of it (f = 0.22 and 0.58 of the full effect). These results identify G310 as the flux-limiting constriction of the activated KCNQ2 pore in our simulations and point to a permeation defect as one component of G310S loss of function.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Qoshimboyev, S., Marimuthu, P., Makhkamov, M., Razzokov, J.. 2026-10-09. A permeable G310 constriction limits K+ flux in the activated KCNQ2 pore and is disrupted by the encephalopathy variant G310S. https://doi.org/10.64898/2026.10.05.756556

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Design of colipids with controlled lateral distance of head group moieties for targeting strategies in the field of lipid-based nanoparticles

Lipid nanoparticles and liposomes are nanoparticle drug formulations which are firmly established in clinics. In order to expand their application and improve efficacy, surface modifications can be a key strategy, especially for cell specific targeting. Targeting can be achieved by integrating ligand functionalized lipids or lipidoids on the nanoparticle surface. In this case, not solely the targeting ligand itself, but also the structure of the whole targeting lipid/lipidoid can affect the interaction of the targeting ligand with the binding motive on cells. Especially, distal spacer structures between lipid anchor and ligand unit, often composed of polyethylene glycol chains, provide a certain distance of the ligand from the nanoparticle surface. A concept which is currently neglected is the control of the lateral distance between ligand structures on the nanoparticle. Herein we investigated the possibility to design lipidoids with a lateral spacer composed of polyethylene glycol units. We synthesized and characterized different lipidoids which provide a primary amine in the head group for possible ligand coupling. In our model lipidoids the head groups were functionalized with a paramagnetic probe to apply electron paramagnetic resonance (EPR) methods for the characterization of the lipidoid interaction with model nanoparticles, in our case liposomes. Continuous wave EPR was used to study the efficiency of the novel lipidoids to integrate into lipid bilayers of model liposomes, which was shown to depend on lipidoid structure and liposome composition. Furthermore, using double electron-electron resonance (DEER), we observed lipidoid conformational changes occurring upon integration into liposomes.

biophysics↗

Binding mechanisms of therapeutic antibodies to human claudin-18.2

Claudin-18.2 (CLDN18.2) is a tight junction component with highly restricted expression in the paracellular space of nonmalignant gastric epithelial cells. It becomes accessible on tumor cell surface during malignant transformation, making CLDN18.2 an attractive target for targeted therapies against gastric cancer. Recently, zolbetuximab has become the first FDA-approved monoclonal antibody that targets CLDN18.2 in advanced gastric cancer, and others like osemitamab have entered phase 3 clinical trials. However, the high-resolution structure of CLDN18.2 is lacking, and how CLDN18.2 is recognized by therapeutic antibodies remains undefined. Here, we report cryo-EM structures of human claudin-18.2 (hCLDN18.2) in complex with the Fab fragments of zolbetuximab and osemitamab, revealing the structure of hCLDN18.2 and its binding mechanism to the therapeutic antibodies. Further analyses reveal that three residues in the first extracellular loop of hCLDN18.2 that are different from human claudin-18.1 (hCLDN18.1) play a critical role in antibody binding. Our data elucidate the structural basis for selective binding of therapeutic antibodies to hCLDN18.2, which should aid rational design of next-generation immunotherapies targeting hCLDN18.2.

biophysics↗

Structural relationships between the SLC12 cotransporter C-terminal domain, universal stress proteins and adenylating enzymes

Several SLC12 cotransporters bind ATP in a cytoplasmic C-terminal domain (CTD). We analysed 16,192 CTD-containing SLC12 sequences and compared 42,845 representative structures to examine the relationship between this nucleotide site, universal stress proteins (USPs) and adenylating enzymes. In phosphorylated NKCC1, D891 and D927 lie near the ATP phosphate chain, while R801 and K889 form a basic phosphate-binding clamp. NKCC1 retains this arrangement, whereas KCC paralogs replace or lose several corresponding groups. In structural comparisons with USP and adenylating-enzyme references, both CTD lobes score between universal stress proteins and EC-annotated domains, and the two lobes form separate lineages that include bacterial transporters. Lobe-specific and nucleotide-frame comparisons place ATP in the corresponding structural region used for -phosphate chemistry by catalytic members of this fold. Published work on UspG provides a precedent for protein-bound AMP in a natural USP. In the examined SLC12 structures and USP models, candidate protein hydroxyls lack an in-line geometry for attack at ATP P. Protein adenylation would require a change in protein or nucleotide geometry, or a different acceptor. These results define a structural basis for testing conditional protein adenylation at SLC12 nucleotide sites. The required evidence is a covalent protein-AMP adduct, identification of its acceptor and measurement of the expected pyrophosphate coproduct, with soluble nucleotide analysis to distinguish accompanying ATP reactions.

biophysics↗